Dietary fat composition and cardiac events in patients with type 2 diabetes

Atherosclerosis

Volumn 236, Issue 1, 2014, Pages

  dos Santos, Ana Luiza Teixeira ^a   Weiss, Tanara ^a   Duarte, Camila Kümmel ^a   Gross, Jorge Luiz ^a   de Azevedo, Mirela Jobim ^a   Zelmanovitz, Themis ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Cardiac events; Dietary fatty acids; Type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; CORN OIL; LINOLENIC ACID; POLYUNSATURATED FATTY ACID; SOYBEAN OIL; VEGETABLE OIL; FAT INTAKE; GLYCOSYLATED HEMOGLOBIN; UNSATURATED FATTY ACID;

ADULT; AGE; ANGINA PECTORIS; ARTICLE; CHOLESTEROL INTAKE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETIC NEPHROPATHY; DIETARY COMPLIANCE; DISEASE DURATION; FAT INTAKE; FEMALE; FOOD COMPOSITION; GENDER; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; HYPERTENSION; LIPID DIET; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SMOKING; SPHYGMOMANOMETER; SUDDEN CARDIAC DEATH; AGED; ANALYSIS; ANTHROPOMETRY; BRAZIL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; FOLLOW UP; HEART DISEASES; HEART FAILURE; KIDNEY FUNCTION TEST; MEDICAL RECORD; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; SUDDEN DEATH; UTILIZATION;

AGED; ALPHA-LINOLENIC ACID; ANGINA PECTORIS; ANTHROPOMETRY; BRAZIL; COMORBIDITY; DEATH, SUDDEN; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIET RECORDS; DIETARY FATS; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOLIPIDEMIC AGENTS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLANT OILS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SMOKING;

EID: 84905862623     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.06.014     Document Type: Article

References (53)

1. Bloomgarden Z.T. Cardiovascular disease and diabetes. Diabetes Care 2003, 26:230-237.
2. Wei M., Gaskill S.P., Haffner S.M., Stern M.P. Effects of diabetes and level of glycemia on all cause and cardiovascular mortality, The San Antonio Heart Study. Diabetes Care 1998, 21(7):1167-1172.
3. Scheffel R.S., Bortolanza D., Weber C.S., Costa L.A., Canani L.H., Santos K.G., et al. Prevalence of micro- and macroangiopathic chronic complications and their risk factors in the care of outpatients with type 2 diabetes mellitus. Rev Assoc Med Bras 2004, 50:263-267.
4. Shepherd J., Barter P., Carmena R., Deedwania P., Fruchart J.C., Haffner S., et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 2006, 29:1220-1226.
5. Cernea S., Hâncu N., Raz I. Diet and coronary heart disease in diabetes. Acta Diabetol 2003, 40:S389-S400.
6. Nutrition Recommendations and Interventions for Diabetes - 2008: A position statement of the American Diabetes Association. Diabetes Care 2008, 31(Supplement 1):S61-S78.
7. Evert A.B., Boucher J.L., Cypress M., Dunbar S.A., Franz M.J., Mayer-Davis E.J., et al. Nutrition Therapy Recommendations for the Management of Adults With Diabetes. Diabetes Care 2014, 37(Supplement 1):S120-S143.
8. Seligman B.G., Biolo A., Polanczyk C.A., Gross J.L., Clausell N. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2000, 23(9):1395-1400.
9. Vaz J.S., Bittencourt M., Almeida J.C., Gross J.L., De Azevedo M.J., Zelmanovitz T. Protein intake estimated by weighed diet records in patients with type 2 diabetes: misreporting and intra-individual variability using 24-hour nitrogen output as criterion standard. J Am Diet Assoc 2008, 108(5):867-872.
10. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinem H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with Impaired glucose tolerance. N Engl J Med 2001, 344(18):1343-1350.
11. Azevedo M.J., Neto A.F.R., Caramori M.L.A., Beck M.O., Moreira J.S.R., Ludwig R., Gross J.L. Value of diagnostic tools for myocardial ischemia used in routine clinical practice to predict cardiac events in patients with Type 2 Diabetes Mellitus: A Prospective Study. Arq Bras Endocrinol Metab 2006, 50(1):46-52.
12. American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care 2014, 37(Suppl. 1):S14-S80.
13. Gross J.L., de Azevedo M.J., Silveiro S.P., Canani L.H., Caramori M.L., Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176.
14. Burke A.P., Farb A., Malcom G.T., Liang Y.H., Smialek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997, 336:1276-1282.
15. Zelmanovitz T., Oliveira J.R., Lulier F., Gross J.L., Azevedo M.J. Avaliação do método imunoturdibimétrico para medida da excreção urinária de albumina em pacientes com diabete melito. Arq Bras Endocrinol Metab 1995, 38:207-211.
16. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med 2011, 364(25):2439-2450.
17. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., et al. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
18. Wang C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006, 84(1):5-17.
19. Djoussé L., Pankow J.S., Eckfeldt J.H. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr 2001, 74(5):612-619.
20. Campos H., Baylin A., Willett W.C. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 2008, 118(4):339-345.
21. Oomen C.M., Ocké M.C., Feskens E.J., Kok F.J., Kromhout D. alpha-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr 2001, 74(4):457-463.
22. Pan A., Chen M., Chowdhury R., Wu J.H., Sun Q., Campos H., et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2012, 96(6):1262-1273.
23. Lemaitre R.N., Sitlani C., Song X., King I.B., McKnight B., Spiegelman D., et al. Circulating and dietary α-linolenic acid and incidence of congestive heart failure in older adults: the Cardiovascular Health Study. Am J Clin Nutr 2012, 96(2):269-274.
24. Djoussé L., Arnett D.K., Carr J.J., Eckfeldt J.H., Hopkins P.N., Province M.A., et al. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 2005, 111:2921-2926.
25. Thies F., Garry J.M., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
26. London B., Albert C., Anderson M.E., Giles W.R., Van Wagoner D.R., Balk E., et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 2007, 116(10):e320-e335.
27. Siscovick D.S., Lemaitre R.N., Mozaffarian D. The Fish Story: A Diet-Heart Hypothesis With Clinical Implications: n-3 Polyunsaturated Fatty Acids, Myocardial Vulnerability, and Sudden Death. Circulation 2003, 107:2632-2634.
28. Mozaffarian D., Ascherio A., Hu F.B., Stampfer M.J., Willett W.C., Siscovick D.S., et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005, 111(2):157-164.
29. Koh A.S., Pan A., Wang R., Odegaard A.O., Pereira M.A., Yuan J.M., et al. The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study. Eur J Prev Cardiol 2013 Dec 16.
30. Albert C.M., Oh K., Whang W., Manson J.E., Chae C.U., Stampfer M.J., et al. Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation 2005, 112(21):3232-3238.
31. Erkkilä A.T., Lichtenstein A.H., Mozaffarian D., Herrington D.M. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 2004, 80:626-632.
32. Almeida J.C., Zelmanovitz T., Vaz J.S., Steemburgo T., Perassolo M.S., Gross J.L., et al. Sources of protein and polyunsaturated fatty acids of the diet and microalbuminuria in type 2 diabetes mellitus. J Am Coll Nutr 2008, 27(5):528-537.
33. Hartweg J., Farmer A.J., Holman R.R., Neil H.A. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 2007, 50(2):250-258.
34. Hu F.B., Cho E., Rexrode K.M., Albert C.M., Manson J.E. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003, 107(14):1852-1857.
35. Mita T., Watada H., Ogihara T., Nomiyama T., Ogawa O., Kinoshita J., et al. Eicosapentaenoic acid reduces the progression of carotid intima-media thickness in patients with type 2 diabetes. Atherosclerosis 2007, 191(1):162-167.
36. Kromhout D., Giltay E.J., Geleijnse J.M. Alpha Omega Trial Group. n-3 Fatty Acids and Cardiovascular Events after Myocardial Infarction. N Engl J Med 2010, 363(21):2015-2026.
37. Thompson FE & Subar AF. Dietary Assessment Methodology. In "Nutrition in the Prevention and Treatment of Disease". Second Edition (Edited by Ann M. Coulston and Carol J. Boushey), pp. 3-39. Elsevier Academic Press, California.
38. Bosch J., Dagenais G.R., Díaz R., Dyal L., Jung H., et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012, 367(4):309-318. ORIGIN Trial Investigators.
39. Singh R.B., Dubnov G., Niaz M.A., Ghosh S., Singh R., Rastogi S.S., et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet 2002, 360(9344):1455-1461.
40. Woodman R.J., Mori T.A., Burke V., Puddey I.B., Watts G.F., Beilin L.J. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002, 76:1007-1015.
41. Friedberg C.E., Janssen M.J., Heine R.J., Grobbee D.E. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998, 21(4):494-500.
42. Balk E.M., Lichtenstein A.H., Chung M., Kupelnick B., Chew P., Lau J. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006, 189(1):19-30.
43. Lang T. Food control or food democracy? Re-engaging nutrition with society and the environment. Public Health Nutr 2005, 8:730-737.
44. von Schacky C., Angerer P., Kothny W., Theisen K., Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130(7):554-562.
45. Kwak S.M., Myung S.K., Lee Y.J., Seo H.G. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med 2012, 172(9):686-694.
46. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): Final report. US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute. Circulation 2002, 106:3143.
47. Ginsberg H.N., Kris-Etherton P., Dennis B., Elmer P.J., Ershow A., Lefevre M., et al. Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the Delta Study, Protocol 1. Arterioscler Thromb Vasc Biol 1998, 18:441-449.
48. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010, 91(3):535-546.
49. Hooper L., Summerbell C.D., Thompson R., Sills D., Roberts F.G., Moore H.J., et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev. 2012, 5.
50. Moulin C.C., Tiskievicz F., Zelmanovitz T., de Oliveira J., Azevedo M.J., Gross J.L. Use ofweighed diet records in thee valuation of diets with different protein contents in patients with type 2 diabetes. Am J Clin Nutr 1998, 67:853-857.
51. Gross J.L., Zelmanovitz T., Moulin C.C., De Mello V., Perassolo M., Leitão C., et al. Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial. Diabetes Care 2002, 25:645-665.
52. de Mello V.D., Zelmanovitz T., Azevedo M.J., de Paula T.P., Gross J.L. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria. J Ren Nutr 2008, 18(5):440-447.
53. Perassolo M., Almeida J.C., Steemburgo T., Dall'Alba V., de Mello V.D., Zelmanovitz T., et al. Endothelial dysfunction and serum fatty acid composition in patients with type 2 diabetes mellitus. Metabolism Clinical and Experimental 2008, 57:1167-1172.